Compounds > amodiaquine

amodiaquine and efavirenz

amodiaquine has been researched along with efavirenz in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Aweeka, FT; Charlebois, E; Coates, C; Dorsey, G; German, P; Greenhouse, B; Havlir, D; Lindegardh, N; Rosenthal, PJ1
Goldstein, JA; Kroetz, DL; Ouedraogo, JB; Parikh, S; Rosenthal, PJ1

Other Studies

3 other study(ies) available for amodiaquine and efavirenz

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Mar-15, Volume: 44, Issue:6

    Topics: Adult; Alkynes; Amodiaquine; Artemisinins; Artesunate; Benzoxazines; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Humans; Liver Diseases; Liver Function Tests; Male; Middle Aged; Oxazines; Reference Values; Risk Assessment; Sesquiterpenes; Transaminases

2007
Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa.
    Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:2

    Topics: Alkynes; Amodiaquine; Antimalarials; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Burkina Faso; Chromatography, High Pressure Liquid; Cyclopropanes; Cytochrome P-450 CYP2C8; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Genotype; HIV Protease Inhibitors; Humans; Lopinavir; Malaria, Falciparum; Models, Biological; Polymorphism, Genetic; Pyridines; Pyrimidinones; Pyrones; Reverse Transcriptase Inhibitors; Saquinavir; Spectrophotometry, Ultraviolet; Sulfonamides; Treatment Outcome; Trimethoprim

2007